{"id":661565,"date":"2026-09-23T11:44:14","date_gmt":"2026-09-23T11:44:14","guid":{"rendered":"https:\/\/Blockchain.News\/news\/20260923-price-prediction-nvda-the-ai-juggernaut-at-229-is"},"modified":"2026-09-23T11:44:14","modified_gmt":"2026-09-23T11:44:14","slug":"nvda-price-prediction-the-ai-juggernaut-at-229-is-coiling-for-a-run-to-240-or-a-trap-door-to-221","status":"publish","type":"post","link":"https:\/\/e-bitco.in\/index.php\/2026\/09\/23\/nvda-price-prediction-the-ai-juggernaut-at-229-is-coiling-for-a-run-to-240-or-a-trap-door-to-221\/","title":{"rendered":"NVDA Price Prediction: The AI Juggernaut at $229 Is Coiling for a Run to $240 \u2014 Or a Trap Door to $221"},"content":{"rendered":"
\n

Lawrence Jengar<\/a> Sep 23, 2026 11:44<\/span> <\/p>\n

NVDA sits at $229.55 with every moving average below it and 58 out of 59 Wall Street analysts rating it a buy \u2014 but a dead-flat MACD and an overbought Stochastic are flashing a short-term warning. …<\/p>\n

\"NVDA <\/a> <\/figure>\n

A $5-Trillion Machine That’s Still Undervalued \u2014 And the Market Is Finally Waking Up<\/h2>\n

NVIDIA doesn’t trade like a semiconductor company anymore. It trades like a toll road on the entire global AI economy. Q2 FY2027 results, reported August 26, made that case louder than any analyst pitch deck: revenue hit $96.2 billion, up 106% year-over-year, with data center revenue alone surging 117% to $89 billion. Gross margins held at 75%. EPS of $2.22 beat consensus by $0.13 \u2014 the fifth consecutive beat. Jensen Huang wasn’t understating it when he said “compute is revenue.” That’s not CEO theater; it’s a description of a structural shift that is still in its early innings.<\/p>\n

What makes the current price entry interesting is the valuation reset that has quietly happened. The trailing P\/E has compressed from 57x a year ago to roughly 27x today. The forward P\/E sits at 23.6x \u2014 historically cheap for a company projecting 93.9% earnings growth in FY2027 and 65.8% in FY2028. The PEG ratio has collapsed to 0.45, which means you are paying less than half a turn of growth for each unit of earnings expansion. For a company with a $5.17 trillion market cap and a $303 billion trailing revenue base, that compression story is what keeps institutional investors reaching for more at every pullback. Readers tracking AI infrastructure stories on Blockchain.news<\/a> will recognize the hyperscaler capex narrative driving this: top-five cloud providers are collectively tracking toward nearly $800 billion in capex in 2026, rising to an estimated $1.3 trillion in 2027. NVIDIA owns the picks-and-shovels position in that buildout, and the guidance for Q3 FY2027 at $108 billion confirms the trajectory isn’t slowing.<\/p>\n

The Technical Structure Says: Buy the Dip, Don’t Chase the Print<\/h2>\n

At $229.55, NVDA is trading cleanly above every meaningful moving average \u2014 the 7-day SMA at $224.66, the 20-day at $222.84, the 50-day at $221.60. That stacking alignment is unambiguously bullish from a trend structure standpoint. The price is also sitting in the upper portion of its Bollinger Band envelope, with the %B reading of 0.77 telling you the stock is elevated relative to its recent range, but not yet at the band extreme. The upper band caps at $235.34, meaning there’s roughly $5.79 of headroom before the stock starts running hot.<\/p>\n

Where this gets nuanced is the momentum picture. The MACD histogram has flat-lined at zero \u2014 the signal and MACD lines are essentially on top of each other. That doesn’t mean reversal; it means the impulse from the last leg higher has been absorbed and buyers need to show up again to extend the move. More pressing is the Stochastic: the %K at 97.22 is deep in overbought territory. In a trending market that kind of reading can persist, but when the MACD is simultaneously stalling, it signals that short-term traders are running out of easy fuel.<\/p>\n

Immediate resistance sits at $231.19, with stronger resistance at $232.82. A clean break above $232.82 on volume would be the green light to extend toward the Bollinger upper band at $235 and then the 52-week high of $236.54. On the downside, immediate support is at $226.86, and the real line in the sand is the $224.16 strong support level \u2014 which also nearly coincides with the 7-day SMA. A close below $224 would signal that the short-term structure has broken and a re-test of the $221-$222 zone, near the 20-day and 50-day MAs, becomes the base case. With a daily ATR of $4.01, any of these moves are entirely achievable within a single session, so position sizing discipline is non-negotiable here.<\/p>\n

The derivatives positioning backs the bullish lean: smart money long\/short ratios sit at 1.62, with 61.8% of top-trader accounts positioned long. Open interest has grown 1.98% in 24 hours to over $156 million in notional value, suggesting fresh money entering rather than short covering. The funding rate at 0.0057% is essentially neutral \u2014 no sign of an overleveraged long side that could trigger a cascade. Taker flow is the one cautionary note, with sell volume slightly edging buy volume at a 0.905 ratio. That’s the market telling you it is absorbing supply rather than aggressively demanding stock. Not a sell signal \u2014 more a “show me” signal. You can track how this setup evolves alongside broader digital asset and equity tokenization developments at Blockchain.news<\/a>.<\/p>\n

Wall Street Has Made Its Call \u2014 And the Numbers Are Unambiguous<\/h2>\n

Fifty-nine analysts cover NVDA. Fifty-eight say buy. One says sell. Two say hold. The mean 12-month price target is $327.70. The high target is $515. The low target is $180. At the current price of $229.55, the consensus mean represents roughly 43% upside over the next 12 months. Goldman Sachs has a $300 target with a buy. BMO Capital is at $340. Cantor Fitzgerald is at $350. TD Cowen sits at $340. Even after five straight earnings beats and a stock already up 20% year-to-date, the sell-side hasn’t blinked.<\/p>\n

The FY2027 EPS consensus has just been revised upward from $8.91 to $9.25 following the August earnings beat, with 13 upward estimate revisions in the past 30 days and zero downward. FY2028 consensus is at $15.33. Put a conservative 22x multiple on the FY2028 number and you’re already at $337 \u2014 above the current Street mean target. That’s the fundamental gravity pulling this stock higher. The company also has $99 billion remaining in its share repurchase authorization and now pays an annual dividend of $1.00, yielding 0.47%. For a name this size to be conducting aggressive buybacks while growing revenue at triple digits is almost absurd from a capital allocation standpoint, and it explains why the institutional ownership base of 71.4% shows no sign of distribution.<\/p>\n

Revenue is guided to accelerate further: sales are projected to rise 88% in FY2027 and another 65.5% in FY2028. At a trailing revenue run rate of $303 billion, this is no longer a small-cap growth story where you close your eyes and pray. This is a company printing cash at a scale that makes the P\/E compression argument almost irresistible to anyone running a 12-18 month book.<\/p>\n

The 7-to-30-Day Trade: Two Paths, One High-Conviction Setup<\/h2>\n

Bull case (65% probability):<\/strong> NVDA consolidates in the $226-$231 range over the next 3-5 sessions, allowing the Stochastic to work off its overbought condition while the MACD begins to recurl upward. A reclaim of $231.19 with volume confirmation \u2014 call it a close above $232 \u2014 opens the door to $235-$236.54 in the near term. Carry that momentum through October and the $241-$245 range becomes the realistic 30-day target as the market begins pricing in Q3 FY2027 numbers (guided at $108 billion). Entry zone:<\/strong> $226-$228 on any intraday dip. Stop:<\/strong> Hard close below $221.50. Target:<\/strong> $238-$245.<\/p>\n

Bear case (35% probability):<\/strong> The flat MACD and overbought Stochastic trigger a more meaningful pullback. Sellers lean on the $231-$232 resistance and push price back through the pivot at $228.49. If $226.86 immediate support cracks on a volume spike, the retracement extends to the $221-$222 zone where the 20-day and 50-day SMAs converge. That level would represent a flush of roughly 3.5% from current levels \u2014 healthy, not catastrophic \u2014 and would actually set up an even cleaner re-entry with better risk\/reward ahead of Q3 earnings. Stop for swing long:<\/strong> $220.99. Do not add below $220<\/strong> without a confirmed reversal candle.<\/p>\n

The medium-term picture \u2014 60 to 90 days \u2014 is harder to fade. With hyperscaler capex commitments locked in, a $108 billion Q3 guidance print, and 58 of 59 analysts holding a buy rating with an average 12-month target 43% above the current price, this stock wants to go higher. The structural AI demand cycle NVIDIA is monetizing isn’t a quarterly narrative; it’s a multi-year infrastructure buildout, and Blockchain.news<\/a> has been tracking the intersection of AI compute and digital infrastructure through each phase of this cycle. Traders who get shaken out at $221 on a technical flush while the fundamentals scream otherwise tend to be the same ones chasing at $280.<\/p>\n

The near-term risk is a technical pause. The medium-term risk is macro \u2014 Fed policy, a risk-off rotation, or any signal that hyperscaler capex commitments are being delayed. Neither of those looks likely in the immediate window. The dominant path is higher.<\/p>\n

\n

Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 23, 2026 and reflect consensus estimates, not investment advice.<\/em><\/p>\n